[Edaily Reporter KIM EUNG-TAE ] U.S. President Donald Trump stated that he maintains good relations with the leaders of nuclear-armed nations and is also on good terms with North Korean State Affairs Commission Chairman Kim Jong-un. President Trump visited the battleground state of Ohio on the 3rd (local time) to campaign. (Photo = Yonhap News) Speaking at a midterm campaign rally in Ohio on the 3rd (local time), President Trump explained why he maintains a good relationship with Chinese President Xi Jinping, saying, “Isn’t it a good thing to maintain good relations with the leaders of huge countries and major nuclear powers?” He added, “I get along very well with Kim Jong-un,” noting, “It’s good to get along when someone has 112 nuclear missiles.” Given that President Trump’s mention of “112 nuclear missiles” came immediately after he referred to Chairman Kim, it is presumed that he was referring to North Korea’s nuclear missiles. However, since this figure differs from the 57 nuclear weapons President Trump cited as North Korea’s stockpile last August, some observers suggest that the exact meaning and basis of his remarks require further clarification. Earlier, on the 29th of last month, President Trump reportedly told reporters at the White House, “Kim Jong-un is my friend. He likes Trump. He doesn’t like many other people,” adding, “I’m the only person in the world he likes, and I like him, too.” He also noted, “He has nuclear capabilities—a very substantial nuclear arsenal,” and remarked, “It’s not as big as ours, but he does have nuclear capabilities.”
(Photo: Blind)
One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
(Graphic: ChatGPT)
“While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…